Influence of protein and albumin levels on serum fructosamine concentration in a diabetic patient with multiple myeloma.
Comtois
R
R
Department of Medicine, Notre-Dame Hospital, University of Montreal, Quebec, Canada.
Couturier
M
M
Ammann
H
H
D001786:Blood Glucose / Q000032:analysis; D001798:Blood Proteins / Q000032:analysis*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D004359:Drug Therapy, Combination; D005260:Female; D019270:Fructosamine; D005938:Glucocorticoids / Q000627:therapeutic use; D006442:Glycated Hemoglobin / Q000032:analysis; D006595:Hexosamines / Q000097:blood*; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D010265:Paraproteinemias / Q000097:blood; D012008:Recurrence; D012709:Serum Albumin / Q000032:analysis*
D001786:Blood Glucose; D001798:Blood Proteins; D019270:Fructosamine; D005938:Glucocorticoids; D006442:Glycated Hemoglobin; D006595:Hexosamines; D007328:Insulin; D008558:Melphalan; D012709:Serum Albumin